Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

88.51
-2.2100-2.44%
Post-market: 88.510.00000.00%19:16 EDT
Volume:2.23M
Turnover:197.92M
Market Cap:5.34B
PE:-188.32
High:91.70
Open:90.73
Low:86.90
Close:90.72
52wk High:109.28
52wk Low:36.88
Shares:60.34M
Float Shares:39.99M
Volume Ratio:2.62
T/O Rate:5.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4700
EPS(LYR):-0.4700
ROE:-8.65%
ROA:-1.83%
PB:16.97
PE(LYR):-188.32

Loading ...

Mirum Pharmaceuticals Announces Health Canada Authorization of Livmarli® Tablet Formulation for the Treatment of Cholestatic Pruritus in Patients With Alagille Syndrome

THOMSON REUTERS
·
Feb 05

Health Canada genehmigt LIVMARLI von Mirum Pharmaceuticals zur Behandlung von cholestatischem Pruritus bei PFIC

Reuters
·
Feb 05

Mirum Pharmaceuticals Announces Health Canada Authorization of Livmarli® for the Treatment of Cholestatic Pruritus in Patients With Progressive Familial Intrahepatic Cholestasis (Pfic)

THOMSON REUTERS
·
Feb 05

Mirum Pharmaceuticals Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Jan 31

Mirum Pharmaceuticals Inc : TD Cowen Raises Target Price to $115 From $95

THOMSON REUTERS
·
Jan 29

Mirum Pharmaceuticals director buys $9.0M in common stock

TIPRANKS
·
Jan 28

Mirum Pharmaceuticals CEO Christopher Peetz Reports Disposal of Common Shares

Reuters
·
Jan 28

Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics

Reuters
·
Jan 26

Mirum Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jan 26

Mirum Pharmaceuticals Inc : Leerink Partners Raises Target Price to $105 From $100

THOMSON REUTERS
·
Jan 26

Mirum Pharmaceuticals price target raised to $130 from $102 at H.C. Wainwright

TIPRANKS
·
Jan 26

HBM Healthcare Investments Reports CHF 286 Million Profit for First Nine Months of 2025/2026

Reuters
·
Jan 23

Evercore ISI Reaffirms Their Buy Rating on Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
Jan 20

Mirum Pharmaceuticals (MIRM) Is Up 5.2% After Issuing Confident 2026 Revenue Outlook and Pipeline Update

Simply Wall St.
·
Jan 19

A Look At Mirum Pharmaceuticals (MIRM) Valuation After Strong Recent Share Price Momentum

Simply Wall St.
·
Jan 18

Director Saira Ramasastry Reports Disposal of Mirum Pharmaceuticals Common Shares

Reuters
·
Jan 17

Mirum Pharmaceuticals Price Target Raised to $102.00/Share From $81.00 by HC Wainwright & Co.

Dow Jones
·
Jan 13

Mirum Pharmaceuticals price target raised to $102 from $81 at H.C. Wainwright

TIPRANKS
·
Jan 13

Mirum Pharmaceuticals Grants Stock Options and RSUs to New Employees

Reuters
·
Jan 13

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jan 13